AI MARKET SCANNING

Dyne Therapeutics Inc

🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP -0.65%
MAX GAP RECORD -5.38%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $DYN
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Jul 30, 2026 Earnings Release 2026-07-30 (BEFORE OPEN)
-2.39%
May 11, 2026 Earnings Release 2026-05-11 (BEFORE OPEN)
-0.28%
Mar 02, 2026 Earnings Release 2026-03-02 (BEFORE OPEN)
-5.38%
Nov 05, 2025 Earnings Release 2025-11-05 (AFTER CLOSE)
+0.77%
Jul 28, 2025 Earnings Release 2025-07-28 (AFTER CLOSE)
+2.04%
May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN)
+0.80%
Feb 27, 2025 Earnings Release 2025-02-27 (BEFORE OPEN)
-0.65%
Nov 12, 2024 Earnings Release 2024-11-12 (BEFORE OPEN)
-0.32%

VOLATILITY & GAP BIAS

AVG GAP MOVE 1.7%
Bullish Gaps (2)
Bearish Gaps (5)
Neutral / Flat (7)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $DYN

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-28 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 135m +3.91%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Dyne Therapeutics, Inc. is a clinical-stage company, which engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystrophy. The company was founded by Jason…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗